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• Contrasting Activation of BNP In Left Vontrloular 
Remodeling due to Prlmar~ Volume Overloa~ or 
Dysfunction 
M,E. Sareno, A, Roost, J,C, Bumett, Jr., J.B, Seward. Mayo foundation 
Rochester, MN, USA 
Left ventricular (LV) remodeling Is assoclatnd with activation of Bml~ natrl- 
uretle boptlde (BNP) but it Is unknown whether different mechanisms of LV 
mmodelleg result In similar elevation of BNP level. Therefore, BNP levels 
(using Rodlolmmunoeesay) end LV remodeling (by Two.dimensional eoho, 
sardiogmphy) worn compared between patients with primely LV volume over- 
load (Mltml regurgtlatlon (MR) with mGurgltant faction ~40%, n • 80) and with 
prtmlw LV dyMunohen (LVD, Ejection fraction <B0%, n - 28)1 LV remodeling 
w~ll lmllar In MR and LVD (LV end.dlHtollo volume Index', t30 21 v8 t41 
40 mUl~2, P~ 0,10; LV Mass: 237 ~ 8,4 ve 260 .+. 77 g, P= 0,t 0), BNP levels In 
both gmupa worn different from age and sex matched normal patients (both P 
,~ 0,001), Significant difference In LV funafton end BNP activation were noted 
between the 2 groups: (where ESVI'. LV end.systolic volume index, EFt LV 
Election fraction, ESW8: LV end.sysfolle wail almost, In multivariate analysis, 
the ESVI was the strongest independent determinant ot BNP level (R2 ,, 0,50, 
P ~ 0,001) Irrespective of the type of LV remodeling (P,~ 0,10), 
MR LVO P 
l~Vt (mL/m~l 4~ r tf~ ~ t ,~3 0,001 
I~F I%l 0~ t ~ ,~ t 9 oo01 
EltW8 (g~n~t ta0 ~ 31 :~11 t 60 0.001 
BNP (pgt~Lt rOt 9? ,185 I ~l~A 0 001 
W~ conc/~t~ that ~NP activation is observed in LV mmndettog 1) whether 
If Is due to p~m~ly volume ovedoad or LV dysfunction, but 2) la slgnlfleantly 
higher In I~tlents with pnmaly LV dysfunction, end 3) In independently deter- 
mined by the inortmsa in LV end, sysfohc v(qume, 
~ _A©ute end Short.term Hemodynsmlc E f fe te  of 
P~fflal Left Vontrloul~¢tomy Analyzed by 
Pressure-Volume Loops 
P, Steandljk, J J, Schmuder, E,H, van dot Veen, ,I, Bean, R,J,V, B~tlsta, 
Let¢l~ UnN~rs~ty &~o~l  Centre, Le~n, 77~ Nett~rl~n(Is 
Introdtaflon: Parilal Left Ventriculo¢tomy (PLV) was introduced as a surgical 
treatment for end.stage heart failure, The traatment consists of partial resec- 
tion of the lateral wall of the left ventricle to reduce diameter, thereby restoring 
normal LV geometry and wall tension, <p>Methods: PLV was performed in 
8 patlents with dilated cardiomyopathy of venous origins (idiopathic (n = 5). 
Ischemic (n = 2), Chagas (n = 1)). Adddion~l surgery included mitral and tri- 
cuspid reconstruchon (n = 7). nght atrial reduction (n = 3), nght ventncular 
reduction (n = 1), LV thrembolectemy in = 1), CABO (n = 2) and aortic valve 
replacement (n == 1) LV function was assessed by continuous LV pressure 
end volume measurements using the conductance catheter at 5 stages: im. 
mediately before surgely (PRE), before a~d after bypass, immediately after 
surgely (POST) and at rocathotorization 3-5 days post-op (RECATH), 
Resulls: Mean resected LV mess was 70 ~ 17 g, Results from PRE, POST 
and RECATH (3.5 ± 1,5 days post-surgery) are given in the table (': p < 0.05 
vs PRE), 
Index PRE POST RECATH 
CI Umi~m ~ 1.5 ~- 05 26 ~: 0,6" 1,8 t 0,3 
EF % 24 ~ 12 48 ~ 7" 43 ± 7' 
EDV ml 238 t: 9 119 ± 31" 119 ~ 27" 
ESV ml 176 ~ 32 63 ~- t9" 70 ~ 17" 
EDF remHg 21 t S 17 ~ 7 22 t 7 
ESP remHg 101 t 29 71 ,L 15 97 ~ 19 
*dP/dt mreHgls 874 ~- 512 891 :L 335 1224 t 406 
T~u ms 50 ± 10 38 ~. 6" 38 ± 5' 
Conctt~on: PLV effectuates ubstantial LV remodeling, accompanied by 
significant improvements in EF and Tau up to 5 days post-op. Contribution of 
additional surgery requires further study. 
~ Determinants of Mltral Regurgitation During 
Induction and Recovery From Heart Failure In ,he 
Conscious dog 
M.G, St John Sutton, H, Patel, T, Plappert, Victor A. Ferrari, E,B. Lankford, 
M, Acker. University of Pennsylvania, Philadelphia, PA, USA 
Mitral regurgitation (MR) frequently develops in heart failure (HF) and may 
accelerate the deterioration in LV function. To investigate the mechanisms 
of MR in HF, we recorded serial 2D Doppler echograms in 18 dogs during 
Induction of HF with rapid vontricular pacing (RVP) at 215 beats/min, and 
during mcovoly alter cessation of RVP in 10 of these dogs, 
Metho¢ls: Serial 20 aches of the LV shon axis, apical 4 chamber and 
long axis views wore obtained at baseline, after 3, 5, 10 weeks of RVP and 
during mcevoly, 3 and 14 weeks after cessation of RVP, We quanhtated LV 
end-diastolic (EDV) and ~)nd-aystollo (ESV) volumes end LVEF using biplane 
Slmpaon'e method. LV mass (LVM). LV shape aa the ratio of short/long axis 
ames (SLAA), mltral an'~ulus diameter (MAD), end sntedor and posterior 
segment lengths from be,el LV ahoR axis aches. Color flow Doppler was uaed 
to grade MR severity fren~ 1+ 1o 4+ In orlhogonal pla~a. 
Result EDV end ESV ¢nemaa~l progressively from '/9 ± 18 to 131 • 26 
ml (p < 0,01) and 35 d: 10 to 98 ± 20 ml (p ~ 0,01 ); LVEF fell from 56 ~ 3 to 26 
8% (p ,~ 0,001) at 10 weeks, while MR g~do Incr~led from 0,$+ to 2,8+ 
(p < 0,00t), LV mess Ingressed prngmsawely, so that LVM/EOV foil from t,4 
0,2 at baaolltto to 1,0 :E 0,1 at 10 weeks, LV ahapp baeeme more sphencaf 
0,3t ~ 0,0Zl to 0,Be • 0,t0 (p -~ 0,01), MAD ettlall~d from 2,8 • 0,~ to 3,3 
0,3 om (p ,~ 0,01) atnd segment I~gthe In¢l'~tsod proportionately, Ounng 
re~voly from HI:, 14 weeks a~ter ~1opplng RVR EOV and ESV decma~ to 
114 ~E 13 ml end 64 ± 14 ml (p -- 0,01) msp~tively w~th • eoncamitant tall 
in MR grade from :2,8+ I0 1,0+, and improvement in LVEF from 12~ ± 6 to 45 
~ 9% (p ,~ 0,0t), Reduction in MR oo~unrnd espite no change in LV Cavity 
shape, segment lengths or MAD, 
~ ; m ;  The (~henges in seventy of MR duneg development and 
ely lmm HF in the o0ns¢tous dog is determined predominantly ~ LV volume 
and not by LV chamber shel~ or the geomotly of the mitml valve apparatus. 
• Exp!snt Myooafdltlot Evldenee for the Role of 
Inflammation In Oeeompenut lon  of Advanced 
Heart Failure Pationts 
B, Bozkurt, RJ, Alvarez, Jr., D.M. McNamam, G.A. MacGowan, 
W,D, Rosanhtum, A,M. Feldman, S. MumlL University ot P~ffsbu~h Medcal 
Caner, P//"~urgh, R4, USA 
Bac~nct ,  Intlamm~toly myocarditts (MYO) has been descnbed on histo- 
logical review of explanted hsalls removed at cardiac trensplantatKm (Tx) In 
pie without a previous olincal ¢hageosis O4 myocardqtls. The ,mplcatmn o4 this 
finding is tlnknown. 
Methods: Explanted cardiac tissue Obtained at Tx or left venmcular al:~Ca| 
core samples removed at the time O4 uentncular assist dewco implantation 
were examined in 221 consocutwe pts with NYHA class IV heart Imlure (HF). 
Pta with prior history el reyocarditis or immunologic ahsorders were excluded. 
MYO was present in 9% (n = 21) O4 pts. Clinm.,al factors iocluding age. gender, 
diagnosis, duration of HF and medication use. viral titres including Epstem- 
Bert, cytomogaiovirus and hepatitis A. B and C and pre-operehve homody- 
namics were compared in pts with (Group A) and without (Group B) MYO. 
Results: 
GROUPS Sat PA immHg) PAWP (mmHg) CI [ I;n~n~m ;) PA 0 2 I%) 
A(n =21) 3?5 1 63  253 ± 4.9 2.0 1 05 492 f 87  
B(n =200) 297' ~ 20 2 iS  J: 102 2,4 ~ 0.5 5632 106 
p • 0.00t < 005 - 005 . 0.005 
PA. PAWP = mean pulmonary artery and mean PA wedge pressures; Ct = cardiac *ndex 
and PAOoSat = PA oxygen saturation Mean age, gender tara. diagnosis, dutat~'l of HF, 
rustication use. and viral tdres were similar in both gloups. 
Conclusmn: 1) MYO is infrequent, though present in pts with advanced 
HI=. 2) Its association with a worse hemodynamic profile suggests that intlam- 
mation may play an important role in the dacomp~,~.,;ation of advanced HF 
pts. 
~ R o l e  of immune Globulin in the Treatment of 
Postpartum Cardlomyopathy 
B. Bozkurt, R.J. AIvarez, Jr., W.D. Rosenblum, GA. MacGowan, 
A.M Feldman, S. Murali, D.M. McNamara. University of Pittsburgh Medics! 
Center, Pittsburgh. PA. USA 
Background:The benefit of intravenous immune globulin (IVIG) in treatment of 
acute cardiomyopathy has recently been described. The etiology and specific 
treatment of postpartum cardiomyopathy (PPC) are unknown. We examined 
the role of WIG i" the treatment of PPC. 
Methods: Five consecutive patients with PPC were treated with WIG 1 
gm/kg for 12 hrs × 2 days at the University of Pittsburgh Medical Center 
between 9/96 and 5/97. Clinical Factors including age, parity, and LVEF, left 
ventricular end diastolic diameter (LVED), NYHA functional class at baseline 
and at three months, were compared to a historical group of 14 patients with 
PPC treated at our center between 1992 and 1997. 
Results: The mean age of the WIG treatment group (T) was 30.8 + 5; the 
control group (C) was 32.2 + 6; parity was 2.4 + 1.1; 2.2 ~: 0.9. 
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LVEF% LVED (cm) N~ HA Class 
Groups Ba~mlme/3 Monlh~, Basekne/3 Months ~seh,~f3 Month~ 
T 2101"5 414z 10 60¢15 52x08 34t04  16*03  
C 21 ~ t 7 30:8 t 8 60 ~. 09 09 ¢ 0.5 2,9 :¢ 0 3 23 ¢ 0,4 
Aft~ treatment ~ NIG, 4/5 i~t~t~ had mgn~ cflmcal nnpmvement; 
LVEF notarized in 3,'5 ~ ,  and impmv~l i~ ~ otl~ patte~ by 16 
poirtts ~10~ 1~ to I~ w~tmvm from ~ I~ft v~t.cular m~t  d~,~e, In 
I !~ COntrOl group, oNy 4/14 pat~ i l~e~l  ~n uttm~le LVEF of ~35 on 
Cor¢/~J0~: NIG lmlmenl may ~ LVEF ~ h~q~al  ~ m 
m ~  w~ IX~t~num c=m~omWCat~ 
• mRNA ~ l o n  of ~ NI t~ Ox l~ 
81mth~e In C~I I~ 11~w of  14men~ Wtlh Hml  
~,al~,m une~ Cm~'rmmm~an~.k)n 
J, 0ms, M ~ ,  M Hera~ E Re~ M R~j~, F R~e~ G Sanz, 
The ~"t~n of lhe ~ ~ ~,"~__ s,p~a~e (iNOS) and the a=m¢~ 
am~ nine m~e (NOz) ~ may ~ m me pamegen~= 
of ~ hea~ ~(HF)  " n ~ w a = ~ m ~ ( p ~ )  
with seven) HF caused bY ~ ~ caR l~f f~y  (IDC) and =s- 
cheme d~ease tlsch) who undan=em heart ~ a~l  m Cmdm¢ dor~s. 
INO~ mRNA eJqpIRt~MsiOII W~S e~iCuatsd m 18fl alld fi~ltl ~l~l~lr,~uk~ ~ by 
RT, PCR "n~ ~ an~l r~m r~xlu~ m pm~ to be 8~7 I~ ~o~e- 
s~( l~g to the eDNA ba~ se¢~eme of human ~NOS. NO~ serum co.cm~ra- 
hen was meesumd by a It~mm~c lechnique./Ul pts were m NYHA class IV 
and (k)nem in class i. ~ n ~  f~r eml ( f~  ~eft 
~nnc~ar d ~  (EOO) and e je~ f ra~ (EF) were c ~  be~ 
~ t ~ , -  Flesuns me m the talge 
IOC Isch 0o,.o~ 
p~ 10 4 4 
Age iV) 55±5 58±2 56±4 
EF (%) 19 : 7 ;~; ~ 2 NO~ 
ED0 (rn~n! 79 ± 10 73 : 7 
,NOS t~m) 100% 20". 0% 
(rd~*nd) 25,3 1:475 56 : 3 40 ~: 2 5 
/n Cor~--/us~n. Pts tnttt HF (rue to IOC had I~gher mc~eftce of iNOS ex- 
~ zn car~ ~.~.~ue attcl hzg~=r plasma NO~. 
~ D D  Genolype of the Angiotensin Converting 
Enzyme Gene Is Associated W'dh a Greater 
Improve l l te l t l  o f  I .e lt  Ve f l ldcu l l r  Funct ion  in 
Patisms With idiopathic Oibted Cam'~,mjo~t~ 
Treated Wilh ACE Inhibilors 
D. Sku~ck'y, I. P, adevskt. G. Car~,  G. Notlo~, P. Samfl. Bata~ 
Hos~fat. Jottannesl~.,g. South/:.:ca 
The DD gePotype of the mser~h0n (IR}) ~ of the ang~o- 
ter~n converting enzyme (ACE) gene has been found to be assooated 
an increased mortality and an increased plasma ACE activity in patients (pts) 
with ddated cam'iomyopatl~ (DCMO). The effect of ACE-inhibilo:s on cardiac 
pedonnance in pts wdh DCMO and camjing edher the D, I 0¢ both alleles has 
not been determined. We followed pmspectevely 59 ~ ~ with DCMO for 
40 ± 10 months (mean age 57 ± 8 y~s, 61% males, radionuctide jec l~ 
fractmn (Rn EF) <40%). All pts were treated with digoxin, furosemide and 
Trandolapnl 4 mg dly. ACE gene distribution was: DD 35%. ID 46% and It 
19%. Baseline dincat characteristics were similar I ~  groups except for 
ejection fraction which was lower in the DD group (p = 0.001). Results of Rn 
EF at baseline and after 1 year el treatment with Trandotaprfl are sho~n in the 
table. 
Baseline 1 year % improvement 
DO (n = 21) 23 ± 5% 39 ± 14%" 67# 
lD/ll (n = 38) 29 ± 6% 38 ± 15%" 36 
• = p < 0.001 companng baseline and 1 year.# = p 004 between the DO and the ID/~I 
group. 
Conclusion: pts with DCMO and DD genotype of the ACE §ene have a 
signdicantly greater improvement in EF than the ID/II group when treated with 
Trandolapril. 
• Slmlladtk~ 6etween Exemlse Cape¢lty and 
YentllMton In PMlent= With Ml',o~,,",onddal 
Myopathy and Chronic Hur t  Fallu~ 
O. Hamnglon, J.S. ~ ,  S,D. A~er, j ,  Moqla~qug~l, 
Na~ ~ r  N~t~ O~m~ tm,~,  UK 
myopathy (MM) i~tmm hewe ~0ar mu=cut~ ct~,  we 
A4~/~¢~ Nif~ MM I~l#~ntl and 9 8gt~, BMI amt lm~ malche¢l h~lltby 
~ were ~ (4~e • 4.7 vs 48.0.3~6y, 2S,e • 13 v 2~e ± 1.e 
~o m~'w were ~ (t~ep~ of r~e ~ line .~a~ venm~e~ (v 
E) and carom d~Ue I~oductmm (V COz ))~ 
Re~,~s: MM ipal~nts had a lower peak V O~ (15,6 ± 1,9 vs 32.4 ~42 
m l ~  p.~ 0.005) am~ooated with il hq]he~ V EN CO= SlOl~ (25.9 ± 1.6 
vs 37'2 P< 0.01 ). The mq~raloW exchange relK~ achieved at peak ~ 
were Ib~m~l~ ( 121 ~ 0.04 vs 125 ± O07 P= NS) 
~ CHF am MM ~ have I ,n~ e=emN te~t abmm~. 
~.  A reduced mu~e m~mt~ ca~¢W may I~m~l peak V O~ a~ ~l  to 
al~om~ mmm~ ve~lal~n. ~ch ~ may o ~  to ~e ab. 
nom~al ,~n l t~ a .~ e~llmcl~le ~Dac~ BBen in CHF  
Ald l l  FlbdllMlon: Mechan!lm; Deflbdllatlon; 
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I 1149-161 l Effect of  Device, medistedTltenzpyon 
SymptomaUc Episodes of  Atrkzl ~ 
C. T i ~ ,  HJ. J. V~-,I~,-~. For l~e Mefmr/m,e~g,=~u~-. Acadenwc 
~ feseamh has shown thai atrial ~l la 'aon (AF) can ~ stmclural 
and elet~ut~y,smk)gz(:aJ c,=,a,-,0es in the atria wt,ch promote the permanence 
ot AF. However. no data ex i les  to wl~ether mten~mtmfl wtlh devme.medmted 
theralw may reveme the changes reduced by AF alx:l thet l~ promole longer 
periods of normal sinus rhythm (NSR). The puq:~e of t t~ sludy was to 
examn~ the frequency of AF mcunerces after ,~plantalmn of the IMetnx 
= m l ~  aln~ def4)nllator (lAD). A total of 51 patzertts (pts) were mlplante¢l 
vv~ a mean f~ow-up of 25~ * ~38 rays. During the s~o'y per i l  of 20 
41 pts sou~t tmatmant fo r~ m- ,e ,~s  AF epis~es (SE), 
mean 6 et~sodes per p~;i~L PIS wifft Mwer ~ 3 SE were e~duded hem the 
analysis. In a~;;o,-,, pts wha e ~  no SE afire an emcdlmy mlenmnlmn 
such as a change m o~g therapy or algal ftuttm ab la l~ were also exdude~L 
For ftte rema~ 21 pls. mean fo~tow-u~ of 231 ± 106 days. ths duretzon 
between ~ were grouped a~o ~ and an average dumUon was 
c~,-,~.,~ fo~ each ¢p~;~. The dmtribution of ff~ese qua~ mmms were 
~re¢ l  u~ng Kal~an-Me~r czn~es. 
Res~.~s: The median quaffffe ~ durations were 7.3.17, 21 ax~l 3S.3 
days f~r the first, se¢on~ ~1 and fourth quarUes respectrve~. The Kaplan- 
Meier curves showed an ~l~reesmg tren¢l m episode ~zration. 
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Conclusion: Preliminary findings from this study suggests that mainte- 
nance of sinus rhythm with an lAD prolongs the interval between symptomatic 
episodes of AF. Further studies are needed to examine this phenomenon 
